Enforcement Policy for Certain Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions: Guidance for Industry and Food and Drug Administration Staff

Information

Type

Guidance

Regulated products

Biologics, Medical Devices

Topics

Premarket

Published

November 2, 2023

Last updated

November 1, 2023

Description

This document is a guidance for industry and FDA staff on the enforcement policy for certain supplements for premarket approval submissions.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed